Global Migraine Headache Drugs Market Growth (Status and Outlook) 2020-2025
Apr, 2020
|
Report ID: 123312
|
131
|
Pharmaceuticals and Healthcare
According to this study, over the next five years the Migraine Headache Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Migraine Headache Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Migraine Headache Drugs market by type, application, key companies and key regions.
This study considers the Migraine Headache Drugs value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Almotriptan
Eletriptan
Sumatriptan
Rizatriptan
Zolmitriptan
Naratriptan
Frovatriptan
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Acute Migraine
Common Migraine
Classic Migraine
Chronic Migraine
Other Migraines
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Grunenthal
Novartis
GSK
Merck
Johnson & Johnson
AstraZeneca
Eli Lilly
Sun Pharma
Teva
Ajanta Pharma
Allergan
Endo Pharmaceuticals
Amneal Pharmaceuticals
Bayer
Apotex
Mylan
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Migraine Headache Drugs market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Migraine Headache Drugs market by identifying its various subsegments.
Focuses on the key global Migraine Headache Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Migraine Headache Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Migraine Headache Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
This report presents a comprehensive overview, market shares and growth opportunities of Migraine Headache Drugs market by type, application, key companies and key regions.
This study considers the Migraine Headache Drugs value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Almotriptan
Eletriptan
Sumatriptan
Rizatriptan
Zolmitriptan
Naratriptan
Frovatriptan
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Acute Migraine
Common Migraine
Classic Migraine
Chronic Migraine
Other Migraines
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Grunenthal
Novartis
GSK
Merck
Johnson & Johnson
AstraZeneca
Eli Lilly
Sun Pharma
Teva
Ajanta Pharma
Allergan
Endo Pharmaceuticals
Amneal Pharmaceuticals
Bayer
Apotex
Mylan
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Migraine Headache Drugs market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Migraine Headache Drugs market by identifying its various subsegments.
Focuses on the key global Migraine Headache Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Migraine Headache Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Migraine Headache Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Migraine Headache Drugs Market Size 2015-2025
2.1.2 Migraine Headache Drugs Market Size CAGR by Region
2.2 Migraine Headache Drugs Segment by Type
2.2.1 Almotriptan
2.2.2 Almotriptan
2.2.3 Sumatriptan
2.2.4 Rizatriptan
2.2.5 Zolmitriptan
2.2.6 Naratriptan
2.2.7 Frovatriptan
2.2.8 Others
2.3 Migraine Headache Drugs Market Size by Type
2.3.1 Global Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
2.3.2 Global Migraine Headache Drugs Market Size Growth Rate by Type (2015-2020)
2.4 Migraine Headache Drugs Segment by Application
2.4.1 Acute Migraine
2.4.2 Common Migraine
2.4.3 Classic Migraine
2.4.4 Chronic Migraine
2.4.5 Other Migraines
2.5 Migraine Headache Drugs Market Size by Application
2.5.1 Global Migraine Headache Drugs Market Size Market Share by Application (2015-2020)
2.5.2 Global Migraine Headache Drugs Market Size Growth Rate by Application (2015-2020)
3 Global Migraine Headache Drugs by Players
3.1 Global Migraine Headache Drugs Market Size Market Share by Players
3.1.1 Global Migraine Headache Drugs Market Size by Players (2018-2020)
3.1.2 Global Migraine Headache Drugs Market Size Market Share by Players (2018-2020)
3.2 Global Migraine Headache Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Migraine Headache Drugs by Regions
4.1 Migraine Headache Drugs Market Size by Regions
4.2 Americas Migraine Headache Drugs Market Size Growth
4.3 APAC Migraine Headache Drugs Market Size Growth
4.4 Europe Migraine Headache Drugs Market Size Growth
4.5 Middle East & Africa Migraine Headache Drugs Market Size Growth
5 Americas
5.1 Americas Migraine Headache Drugs Market Size by Countries
5.2 Americas Migraine Headache Drugs Market Size by Type
5.3 Americas Migraine Headache Drugs Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Migraine Headache Drugs Market Size by Regions
6.2 APAC Migraine Headache Drugs Market Size by Type
6.3 APAC Migraine Headache Drugs Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Migraine Headache Drugs by Countries
7.2 Europe Migraine Headache Drugs Market Size by Type
7.3 Europe Migraine Headache Drugs Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Migraine Headache Drugs by Countries
8.2 Middle East & Africa Migraine Headache Drugs Market Size by Type
8.3 Middle East & Africa Migraine Headache Drugs Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Migraine Headache Drugs Market Forecast
10.1 Global Migraine Headache Drugs Market Size Forecast (2021-2025)
10.2 Global Migraine Headache Drugs Forecast by Regions
10.2.1 Global Migraine Headache Drugs Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Migraine Headache Drugs Forecast by Type
10.8 Global Migraine Headache Drugs Forecast by Application
11 Key Players Analysis
11.1 Pfizer
11.1.1 Company Details
11.1.2 Migraine Headache Drugs Product Offered
11.1.3 Pfizer Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Pfizer News
11.2 Grunenthal
11.2.1 Company Details
11.2.2 Migraine Headache Drugs Product Offered
11.2.3 Grunenthal Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Grunenthal News
11.3 Novartis
11.3.1 Company Details
11.3.2 Migraine Headache Drugs Product Offered
11.3.3 Novartis Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Novartis News
11.4 GSK
11.4.1 Company Details
11.4.2 Migraine Headache Drugs Product Offered
11.4.3 GSK Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 GSK News
11.5 Merck
11.5.1 Company Details
11.5.2 Migraine Headache Drugs Product Offered
11.5.3 Merck Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Merck News
11.6 Johnson & Johnson
11.6.1 Company Details
11.6.2 Migraine Headache Drugs Product Offered
11.6.3 Johnson & Johnson Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Johnson & Johnson News
11.7 AstraZeneca
11.7.1 Company Details
11.7.2 Migraine Headache Drugs Product Offered
11.7.3 AstraZeneca Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 AstraZeneca News
11.8 Eli Lilly
11.8.1 Company Details
11.8.2 Migraine Headache Drugs Product Offered
11.8.3 Eli Lilly Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Eli Lilly News
11.9 Sun Pharma
11.9.1 Company Details
11.9.2 Migraine Headache Drugs Product Offered
11.9.3 Sun Pharma Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Sun Pharma News
11.10 Teva
11.10.1 Company Details
11.10.2 Migraine Headache Drugs Product Offered
11.10.3 Teva Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Teva News
11.11 Ajanta Pharma
11.12 Allergan
11.13 Endo Pharmaceuticals
11.14 Amneal Pharmaceuticals
11.15 Bayer
11.16 Apotex
11.17 Mylan
12 Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Migraine Headache Drugs Market Size 2015-2025
2.1.2 Migraine Headache Drugs Market Size CAGR by Region
2.2 Migraine Headache Drugs Segment by Type
2.2.1 Almotriptan
2.2.2 Almotriptan
2.2.3 Sumatriptan
2.2.4 Rizatriptan
2.2.5 Zolmitriptan
2.2.6 Naratriptan
2.2.7 Frovatriptan
2.2.8 Others
2.3 Migraine Headache Drugs Market Size by Type
2.3.1 Global Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
2.3.2 Global Migraine Headache Drugs Market Size Growth Rate by Type (2015-2020)
2.4 Migraine Headache Drugs Segment by Application
2.4.1 Acute Migraine
2.4.2 Common Migraine
2.4.3 Classic Migraine
2.4.4 Chronic Migraine
2.4.5 Other Migraines
2.5 Migraine Headache Drugs Market Size by Application
2.5.1 Global Migraine Headache Drugs Market Size Market Share by Application (2015-2020)
2.5.2 Global Migraine Headache Drugs Market Size Growth Rate by Application (2015-2020)
3 Global Migraine Headache Drugs by Players
3.1 Global Migraine Headache Drugs Market Size Market Share by Players
3.1.1 Global Migraine Headache Drugs Market Size by Players (2018-2020)
3.1.2 Global Migraine Headache Drugs Market Size Market Share by Players (2018-2020)
3.2 Global Migraine Headache Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Migraine Headache Drugs by Regions
4.1 Migraine Headache Drugs Market Size by Regions
4.2 Americas Migraine Headache Drugs Market Size Growth
4.3 APAC Migraine Headache Drugs Market Size Growth
4.4 Europe Migraine Headache Drugs Market Size Growth
4.5 Middle East & Africa Migraine Headache Drugs Market Size Growth
5 Americas
5.1 Americas Migraine Headache Drugs Market Size by Countries
5.2 Americas Migraine Headache Drugs Market Size by Type
5.3 Americas Migraine Headache Drugs Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Migraine Headache Drugs Market Size by Regions
6.2 APAC Migraine Headache Drugs Market Size by Type
6.3 APAC Migraine Headache Drugs Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Migraine Headache Drugs by Countries
7.2 Europe Migraine Headache Drugs Market Size by Type
7.3 Europe Migraine Headache Drugs Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Migraine Headache Drugs by Countries
8.2 Middle East & Africa Migraine Headache Drugs Market Size by Type
8.3 Middle East & Africa Migraine Headache Drugs Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Migraine Headache Drugs Market Forecast
10.1 Global Migraine Headache Drugs Market Size Forecast (2021-2025)
10.2 Global Migraine Headache Drugs Forecast by Regions
10.2.1 Global Migraine Headache Drugs Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Migraine Headache Drugs Forecast by Type
10.8 Global Migraine Headache Drugs Forecast by Application
11 Key Players Analysis
11.1 Pfizer
11.1.1 Company Details
11.1.2 Migraine Headache Drugs Product Offered
11.1.3 Pfizer Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Pfizer News
11.2 Grunenthal
11.2.1 Company Details
11.2.2 Migraine Headache Drugs Product Offered
11.2.3 Grunenthal Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Grunenthal News
11.3 Novartis
11.3.1 Company Details
11.3.2 Migraine Headache Drugs Product Offered
11.3.3 Novartis Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Novartis News
11.4 GSK
11.4.1 Company Details
11.4.2 Migraine Headache Drugs Product Offered
11.4.3 GSK Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 GSK News
11.5 Merck
11.5.1 Company Details
11.5.2 Migraine Headache Drugs Product Offered
11.5.3 Merck Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Merck News
11.6 Johnson & Johnson
11.6.1 Company Details
11.6.2 Migraine Headache Drugs Product Offered
11.6.3 Johnson & Johnson Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Johnson & Johnson News
11.7 AstraZeneca
11.7.1 Company Details
11.7.2 Migraine Headache Drugs Product Offered
11.7.3 AstraZeneca Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 AstraZeneca News
11.8 Eli Lilly
11.8.1 Company Details
11.8.2 Migraine Headache Drugs Product Offered
11.8.3 Eli Lilly Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Eli Lilly News
11.9 Sun Pharma
11.9.1 Company Details
11.9.2 Migraine Headache Drugs Product Offered
11.9.3 Sun Pharma Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Sun Pharma News
11.10 Teva
11.10.1 Company Details
11.10.2 Migraine Headache Drugs Product Offered
11.10.3 Teva Migraine Headache Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Teva News
11.11 Ajanta Pharma
11.12 Allergan
11.13 Endo Pharmaceuticals
11.14 Amneal Pharmaceuticals
11.15 Bayer
11.16 Apotex
11.17 Mylan
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Migraine Headache Drugs Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Almotriptan
Table 5. Major Players of Eletriptan
Table 6. Major Players of Sumatriptan
Table 7. Major Players of Rizatriptan
Table 8. Major Players of Zolmitriptan
Table 9. Major Players of Naratriptan
Table 10. Major Players of Frovatriptan
Table 11. Major Players of Others
Table 12. Migraine Headache Drugs Market Size by Type (2014-2019) ($ Millions)
Table 13. Global Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
Table 14. Global Migraine Headache Drugs Market Size by Application (2015-2020) ($ Millions)
Table 15. Global Migraine Headache Drugs Market Size Market Share by Application (2015-2020)
Table 16. Global Migraine Headache Drugs Revenue by Players (2018-2020) ($ Millions)
Table 17. Global Migraine Headache Drugs Revenue Market Share by Players (2018-2020)
Table 18. Global Migraine Headache Drugs Key Players Head office and Products Offered
Table 19. Migraine Headache Drugs Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Migraine Headache Drugs Market Size by Regions 2015-2020 ($ Millions)
Table 23. Global Migraine Headache Drugs Market Size Market Share by Regions 2015-2020
Table 24. Americas Migraine Headache Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 25. Americas Migraine Headache Drugs Market Size Market Share by Countries (2015-2020)
Table 26. Americas Migraine Headache Drugs Market Size by Type (2015-2020) ($ Millions)
Table 27. Americas Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
Table 28. Americas Migraine Headache Drugs Market Size by Application (2015-2020) ($ Millions)
Table 29. Americas Migraine Headache Drugs Market Size Market Share by Application (2015-2020)
Table 30. APAC Migraine Headache Drugs Market Size by Regions (2015-2020) ($ Millions)
Table 31. APAC Migraine Headache Drugs Market Size Market Share by Regions (2015-2020)
Table 32. APAC Migraine Headache Drugs Market Size by Type (2015-2020) ($ Millions)
Table 33. APAC Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
Table 34. APAC Migraine Headache Drugs Market Size by Application (2015-2020) ($ Millions)
Table 35. APAC Migraine Headache Drugs Market Size Market Share by Application (2015-2020)
Table 36. Europe Migraine Headache Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 37. Europe Migraine Headache Drugs Market Size Market Share by Countries (2015-2020)
Table 38. Europe Migraine Headache Drugs Market Size by Type (2015-2020) ($ Millions)
Table 39. Europe Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
Table 40. Europe Migraine Headache Drugs Market Size by Application (2015-2020) ($ Millions)
Table 41. Europe Migraine Headache Drugs Market Size Market Share by Application (2015-2020)
Table 42. Middle East & Africa Migraine Headache Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 43. Middle East & Africa Migraine Headache Drugs Market Size Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Migraine Headache Drugs Market Size by Type (2015-2020) ($ Millions)
Table 45. Middle East & Africa Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
Table 46. Middle East & Africa Migraine Headache Drugs Market Size by Application (2015-2020) ($ Millions)
Table 47. Middle East & Africa Migraine Headache Drugs Market Size Market Share by Application (2015-2020)
Table 48. Key and Potential Regions of Migraine Headache Drugs
Table 49. Key Application and Potential Industries of Migraine Headache Drugs
Table 50. Key Challenges of Migraine Headache Drugs
Table 51. Key Trends of Migraine Headache Drugs
Table 52. Global Migraine Headache Drugs Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 53. Global Migraine Headache Drugs Market Size Market Share Forecast by Regions
Table 54. Global Migraine Headache Drugs Market Size Forecast by Type (2021-2025) ($ Millions)
Table 55. Global Migraine Headache Drugs Market Size Market Share Forecast by Type (2021-2025)
Table 56. Global Migraine Headache Drugs Market Size Forecast by Application (2021-2025) ($ Millions)
Table 57. Global Migraine Headache Drugs Market Size Market Share Forecast by Application (2021-2025)
Table 58. Pfizer Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 59. Pfizer Migraine Headache Drugs Product Offered
Table 60. Pfizer Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 61. Pfizer Main Business
Table 62. Pfizer Latest Developments
Table 63. Grunenthal Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 64. Grunenthal Migraine Headache Drugs Product Offered
Table 65. Grunenthal Main Business
Table 66. Grunenthal Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 67. Grunenthal Latest Developments
Table 68. Novartis Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 69. Novartis Migraine Headache Drugs Product Offered
Table 70. Novartis Main Business
Table 71. Novartis Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 72. Novartis Latest Developments
Table 73. GSK Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 74. GSK Migraine Headache Drugs Product Offered
Table 75. GSK Main Business
Table 76. GSK Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 77. GSK Latest Developments
Table 78. Merck Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 79. Merck Migraine Headache Drugs Product Offered
Table 80. Merck Main Business
Table 81. Merck Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 82. Merck Latest Developments
Table 83. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 84. Johnson & Johnson Migraine Headache Drugs Product Offered
Table 85. Johnson & Johnson Main Business
Table 86. Johnson & Johnson Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 87. Johnson & Johnson Latest Developments
Table 88. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 89. AstraZeneca Migraine Headache Drugs Product Offered
Table 90. AstraZeneca Main Business
Table 91. AstraZeneca Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 92. AstraZeneca Latest Developments
Table 93. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 94. Eli Lilly Migraine Headache Drugs Product Offered
Table 95. Eli Lilly Main Business
Table 96. Eli Lilly Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 97. Eli Lilly Latest Developments
Table 98. Sun Pharma Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 99. Sun Pharma Migraine Headache Drugs Product Offered
Table 100. Sun Pharma Main Business
Table 101. Sun Pharma Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 102. Sun Pharma Latest Developments
Table 103. Teva Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 104. Teva Migraine Headache Drugs Product Offered
Table 105. Teva Main Business
Table 106. Teva Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 107. Teva Latest Developments
Table 108. Ajanta Pharma Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 109. Allergan Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 110. Endo Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 111. Amneal Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 112. Bayer Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 113. Apotex Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 114. Mylan Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
List of Figures
Figure 1. Migraine Headache Drugs Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Migraine Headache Drugs Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
Figure 5. Global Almotriptan Market Size Growth Rate
Figure 6. Global Eletriptan Market Size Growth Rate
Figure 7. Global Sumatriptan Market Size Growth Rate
Figure 8. Global Rizatriptan Market Size Growth Rate
Figure 9. Global Zolmitriptan Market Size Growth Rate
Figure 10. Global Naratriptan Market Size Growth Rate
Figure 11. Global Frovatriptan Market Size Growth Rate
Figure 12. Global Others Market Size Growth Rate
Figure 13. Migraine Headache Drugs in Acute Migraine
Figure 14. Global Migraine Headache Drugs Market: Acute Migraine (2015-2020) ($ Millions)
Figure 15. Migraine Headache Drugs in Common Migraine
Figure 16. Global Migraine Headache Drugs Market: Common Migraine (2015-2020) ($ Millions)
Figure 17. Migraine Headache Drugs in Classic Migraine
Figure 18. Global Migraine Headache Drugs Market: Classic Migraine (2015-2020) ($ Millions)
Figure 19. Global Classic Migraine YoY Growth ($ Millions)
Figure 20. Migraine Headache Drugs in Chronic Migraine
Figure 21. Global Migraine Headache Drugs Market: Chronic Migraine (2015-2020) ($ Millions)
Figure 22. Global Chronic Migraine YoY Growth ($ Millions)
Figure 23. Migraine Headache Drugs in Other Migraines
Figure 24. Global Migraine Headache Drugs Market: Other Migraines (2015-2020) ($ Millions)
Figure 25. Global Other Migraines YoY Growth ($ Millions)
Figure 26. Global Migraine Headache Drugs Market Size Market Share by Application in 2019
Figure 27. Global Migraine Headache Drugs Market Size Market Share by Regions 2015-2020
Figure 28. Americas Migraine Headache Drugs Market Size 2015-2020 ($ Millions)
Figure 29. APAC Migraine Headache Drugs Market Size 2015-2020 ($ Millions)
Figure 30. Europe Migraine Headache Drugs Market Size 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Migraine Headache Drugs Market Size 2015-2020 ($ Millions)
Figure 32. Americas Migraine Headache Drugs Market Size Market Share by Countries in 2019
Figure 33. Americas Migraine Headache Drugs Market Size Market Share by Type in 2019
Figure 34. Americas Migraine Headache Drugs Market Size Market Share by Application in 2019
Figure 35. United States Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 36. Canada Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 37. Mexico Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 38. APAC Migraine Headache Drugs Market Size Market Share by Regions in 2019
Figure 39. APAC Migraine Headache Drugs Market Size Market Share by Type in 2019
Figure 40. APAC Migraine Headache Drugs Market Size Market Share by Application in 2019
Figure 41. China Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 42. Japan Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 43. Korea Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 44. Southeast Asia Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 45. India Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 46. Australia Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 47. Europe Migraine Headache Drugs Market Size Market Share by Countries in 2019
Figure 48. Europe Migraine Headache Drugs Market Size Market Share by Type in 2019
Figure 49. Europe Migraine Headache Drugs Market Size Market Share by Application in 2019
Figure 50. Germany Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 51. France Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 52. UK Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 53. Italy Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 54. Russia Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 55. Spain Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 56. Middle East & Africa Migraine Headache Drugs Market Size Market Share by Countries in 2019
Figure 57. Middle East & Africa Migraine Headache Drugs Market Size Market Share by Type in 2019
Figure 58. Middle East & Africa Migraine Headache Drugs Market Size Market Share by Application in 2019
Figure 59. Egypt Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 60. South Africa Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 61. Israel Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 62. Turkey Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 63. GCC Countries Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 64. Global Migraine Headache Drugs arket Size Forecast (2021-2025) ($ Millions)
Figure 65. Americas Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 66. APAC Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 67. Europe Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 68. Middle East & Africa Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 69. United States Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 70. Canada Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 71. Mexico Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 72. Brazil Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 73. China Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 74. Japan Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 75. Korea Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 76. Southeast Asia Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 77. India Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 78. Australia Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 79. Germany Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 80. France Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 81. UK Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 82. Italy Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 83. Russia Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 84. Spain Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 85. Egypt Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 86. South Africa Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 87. Israel Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 88. Turkey Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 89. GCC Countries Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Table 1. Research Methodology
Table 2. Data Source
Table 3. Migraine Headache Drugs Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Almotriptan
Table 5. Major Players of Eletriptan
Table 6. Major Players of Sumatriptan
Table 7. Major Players of Rizatriptan
Table 8. Major Players of Zolmitriptan
Table 9. Major Players of Naratriptan
Table 10. Major Players of Frovatriptan
Table 11. Major Players of Others
Table 12. Migraine Headache Drugs Market Size by Type (2014-2019) ($ Millions)
Table 13. Global Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
Table 14. Global Migraine Headache Drugs Market Size by Application (2015-2020) ($ Millions)
Table 15. Global Migraine Headache Drugs Market Size Market Share by Application (2015-2020)
Table 16. Global Migraine Headache Drugs Revenue by Players (2018-2020) ($ Millions)
Table 17. Global Migraine Headache Drugs Revenue Market Share by Players (2018-2020)
Table 18. Global Migraine Headache Drugs Key Players Head office and Products Offered
Table 19. Migraine Headache Drugs Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Migraine Headache Drugs Market Size by Regions 2015-2020 ($ Millions)
Table 23. Global Migraine Headache Drugs Market Size Market Share by Regions 2015-2020
Table 24. Americas Migraine Headache Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 25. Americas Migraine Headache Drugs Market Size Market Share by Countries (2015-2020)
Table 26. Americas Migraine Headache Drugs Market Size by Type (2015-2020) ($ Millions)
Table 27. Americas Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
Table 28. Americas Migraine Headache Drugs Market Size by Application (2015-2020) ($ Millions)
Table 29. Americas Migraine Headache Drugs Market Size Market Share by Application (2015-2020)
Table 30. APAC Migraine Headache Drugs Market Size by Regions (2015-2020) ($ Millions)
Table 31. APAC Migraine Headache Drugs Market Size Market Share by Regions (2015-2020)
Table 32. APAC Migraine Headache Drugs Market Size by Type (2015-2020) ($ Millions)
Table 33. APAC Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
Table 34. APAC Migraine Headache Drugs Market Size by Application (2015-2020) ($ Millions)
Table 35. APAC Migraine Headache Drugs Market Size Market Share by Application (2015-2020)
Table 36. Europe Migraine Headache Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 37. Europe Migraine Headache Drugs Market Size Market Share by Countries (2015-2020)
Table 38. Europe Migraine Headache Drugs Market Size by Type (2015-2020) ($ Millions)
Table 39. Europe Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
Table 40. Europe Migraine Headache Drugs Market Size by Application (2015-2020) ($ Millions)
Table 41. Europe Migraine Headache Drugs Market Size Market Share by Application (2015-2020)
Table 42. Middle East & Africa Migraine Headache Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 43. Middle East & Africa Migraine Headache Drugs Market Size Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Migraine Headache Drugs Market Size by Type (2015-2020) ($ Millions)
Table 45. Middle East & Africa Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
Table 46. Middle East & Africa Migraine Headache Drugs Market Size by Application (2015-2020) ($ Millions)
Table 47. Middle East & Africa Migraine Headache Drugs Market Size Market Share by Application (2015-2020)
Table 48. Key and Potential Regions of Migraine Headache Drugs
Table 49. Key Application and Potential Industries of Migraine Headache Drugs
Table 50. Key Challenges of Migraine Headache Drugs
Table 51. Key Trends of Migraine Headache Drugs
Table 52. Global Migraine Headache Drugs Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 53. Global Migraine Headache Drugs Market Size Market Share Forecast by Regions
Table 54. Global Migraine Headache Drugs Market Size Forecast by Type (2021-2025) ($ Millions)
Table 55. Global Migraine Headache Drugs Market Size Market Share Forecast by Type (2021-2025)
Table 56. Global Migraine Headache Drugs Market Size Forecast by Application (2021-2025) ($ Millions)
Table 57. Global Migraine Headache Drugs Market Size Market Share Forecast by Application (2021-2025)
Table 58. Pfizer Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 59. Pfizer Migraine Headache Drugs Product Offered
Table 60. Pfizer Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 61. Pfizer Main Business
Table 62. Pfizer Latest Developments
Table 63. Grunenthal Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 64. Grunenthal Migraine Headache Drugs Product Offered
Table 65. Grunenthal Main Business
Table 66. Grunenthal Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 67. Grunenthal Latest Developments
Table 68. Novartis Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 69. Novartis Migraine Headache Drugs Product Offered
Table 70. Novartis Main Business
Table 71. Novartis Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 72. Novartis Latest Developments
Table 73. GSK Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 74. GSK Migraine Headache Drugs Product Offered
Table 75. GSK Main Business
Table 76. GSK Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 77. GSK Latest Developments
Table 78. Merck Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 79. Merck Migraine Headache Drugs Product Offered
Table 80. Merck Main Business
Table 81. Merck Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 82. Merck Latest Developments
Table 83. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 84. Johnson & Johnson Migraine Headache Drugs Product Offered
Table 85. Johnson & Johnson Main Business
Table 86. Johnson & Johnson Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 87. Johnson & Johnson Latest Developments
Table 88. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 89. AstraZeneca Migraine Headache Drugs Product Offered
Table 90. AstraZeneca Main Business
Table 91. AstraZeneca Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 92. AstraZeneca Latest Developments
Table 93. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 94. Eli Lilly Migraine Headache Drugs Product Offered
Table 95. Eli Lilly Main Business
Table 96. Eli Lilly Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 97. Eli Lilly Latest Developments
Table 98. Sun Pharma Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 99. Sun Pharma Migraine Headache Drugs Product Offered
Table 100. Sun Pharma Main Business
Table 101. Sun Pharma Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 102. Sun Pharma Latest Developments
Table 103. Teva Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 104. Teva Migraine Headache Drugs Product Offered
Table 105. Teva Main Business
Table 106. Teva Migraine Headache Drugs Revenue and Gross Margin (2018-2020E)
Table 107. Teva Latest Developments
Table 108. Ajanta Pharma Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 109. Allergan Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 110. Endo Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 111. Amneal Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 112. Bayer Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 113. Apotex Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
Table 114. Mylan Details, Company Total Revenue (in $ million), Head Office, Migraine Headache Drugs Major Market Areas and Its Competitors
List of Figures
Figure 1. Migraine Headache Drugs Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Migraine Headache Drugs Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Migraine Headache Drugs Market Size Market Share by Type (2015-2020)
Figure 5. Global Almotriptan Market Size Growth Rate
Figure 6. Global Eletriptan Market Size Growth Rate
Figure 7. Global Sumatriptan Market Size Growth Rate
Figure 8. Global Rizatriptan Market Size Growth Rate
Figure 9. Global Zolmitriptan Market Size Growth Rate
Figure 10. Global Naratriptan Market Size Growth Rate
Figure 11. Global Frovatriptan Market Size Growth Rate
Figure 12. Global Others Market Size Growth Rate
Figure 13. Migraine Headache Drugs in Acute Migraine
Figure 14. Global Migraine Headache Drugs Market: Acute Migraine (2015-2020) ($ Millions)
Figure 15. Migraine Headache Drugs in Common Migraine
Figure 16. Global Migraine Headache Drugs Market: Common Migraine (2015-2020) ($ Millions)
Figure 17. Migraine Headache Drugs in Classic Migraine
Figure 18. Global Migraine Headache Drugs Market: Classic Migraine (2015-2020) ($ Millions)
Figure 19. Global Classic Migraine YoY Growth ($ Millions)
Figure 20. Migraine Headache Drugs in Chronic Migraine
Figure 21. Global Migraine Headache Drugs Market: Chronic Migraine (2015-2020) ($ Millions)
Figure 22. Global Chronic Migraine YoY Growth ($ Millions)
Figure 23. Migraine Headache Drugs in Other Migraines
Figure 24. Global Migraine Headache Drugs Market: Other Migraines (2015-2020) ($ Millions)
Figure 25. Global Other Migraines YoY Growth ($ Millions)
Figure 26. Global Migraine Headache Drugs Market Size Market Share by Application in 2019
Figure 27. Global Migraine Headache Drugs Market Size Market Share by Regions 2015-2020
Figure 28. Americas Migraine Headache Drugs Market Size 2015-2020 ($ Millions)
Figure 29. APAC Migraine Headache Drugs Market Size 2015-2020 ($ Millions)
Figure 30. Europe Migraine Headache Drugs Market Size 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Migraine Headache Drugs Market Size 2015-2020 ($ Millions)
Figure 32. Americas Migraine Headache Drugs Market Size Market Share by Countries in 2019
Figure 33. Americas Migraine Headache Drugs Market Size Market Share by Type in 2019
Figure 34. Americas Migraine Headache Drugs Market Size Market Share by Application in 2019
Figure 35. United States Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 36. Canada Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 37. Mexico Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 38. APAC Migraine Headache Drugs Market Size Market Share by Regions in 2019
Figure 39. APAC Migraine Headache Drugs Market Size Market Share by Type in 2019
Figure 40. APAC Migraine Headache Drugs Market Size Market Share by Application in 2019
Figure 41. China Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 42. Japan Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 43. Korea Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 44. Southeast Asia Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 45. India Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 46. Australia Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 47. Europe Migraine Headache Drugs Market Size Market Share by Countries in 2019
Figure 48. Europe Migraine Headache Drugs Market Size Market Share by Type in 2019
Figure 49. Europe Migraine Headache Drugs Market Size Market Share by Application in 2019
Figure 50. Germany Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 51. France Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 52. UK Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 53. Italy Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 54. Russia Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 55. Spain Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 56. Middle East & Africa Migraine Headache Drugs Market Size Market Share by Countries in 2019
Figure 57. Middle East & Africa Migraine Headache Drugs Market Size Market Share by Type in 2019
Figure 58. Middle East & Africa Migraine Headache Drugs Market Size Market Share by Application in 2019
Figure 59. Egypt Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 60. South Africa Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 61. Israel Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 62. Turkey Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 63. GCC Countries Migraine Headache Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 64. Global Migraine Headache Drugs arket Size Forecast (2021-2025) ($ Millions)
Figure 65. Americas Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 66. APAC Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 67. Europe Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 68. Middle East & Africa Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 69. United States Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 70. Canada Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 71. Mexico Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 72. Brazil Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 73. China Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 74. Japan Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 75. Korea Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 76. Southeast Asia Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 77. India Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 78. Australia Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 79. Germany Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 80. France Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 81. UK Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 82. Italy Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 83. Russia Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 84. Spain Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 85. Egypt Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 86. South Africa Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 87. Israel Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 88. Turkey Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
Figure 89. GCC Countries Migraine Headache Drugs Market Size 2021-2025 ($ Millions)
